Which pharmaceutical product was the first FDA-approved monoclonal antibody for the treatment of cancer?

The medical industry has seen remarkable product innovations that have revolutionized patient care and treatment outcomes. One such breakthrough changed how certain diseases are treated by introducing a completely new mechanism of action. Test your knowledge about this significant pharmaceutical advancement that transformed the medical landscape and earned its creator recognition in the scientific community.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Rituximab (Rituxan), approved in 1997 for non-Hodgkin's lymphoma
Trastuzumab (Herceptin), approved in 1998 for breast cancer
Infliximab (Remicade), approved in 1998 for Crohn's disease
Adalimumab (Humira), approved in 2002 for rheumatoid arthritis